Bryan Therapeutics Warns of Counterfeit Nitric Oxide Products, Urges Consumer Caution

Bryan Therapeutics has issued a warning about counterfeit versions of its N1o1 and NO2U nitric oxide products, citing significant safety concerns for consumers. The company's CEO, Dr. Nathan S. Bryan, stated that products appearing to originate from Bryan Therapeutics but sold by unauthorized sellers may be stolen goods or counterfeit, presenting a risk to health. According to the company, these counterfeit products represent a severe safety concern since their composition is unknown, and therefore their efficacy or safety cannot be guaranteed. Dr. Bryan emphasized that Bryan Therapeutics produces nitric oxide-based consumer products based on over 25 years of research, discoveries, and innovation, with products that actually produce nitric oxide when consumed. He noted that the N1o1 and NO2U line are market leaders because they work, making the emergence of counterfeits particularly troubling. The company has identified a number of counterfeit products using its trademarked brands and is taking the issue seriously to protect consumers.

Susan Shaffer, President of Bryan Therapeutics, advised consumers to buy only from official sources to ensure authenticity. She specified that when shopping online, purchases should be made directly from www.N1o1.com or www.NO2U.com, or from the company's official Amazon store. On Amazon, products must show "Sold By: Pneuma Nitric Oxide LLC, NO2U, or Bryan Nitriceuticals" to be authentic. Shaffer clarified that Bryan Therapeutics does not sell on eBay or other third-party sites besides Amazon and its own storefronts, and she provided contact information for verification, though consumers are encouraged to use official channels first. This guidance is crucial as counterfeit health products in online marketplaces can exploit consumer trust, leading to potential harm from ineffective or dangerous ingredients.

To address the issue, Bryan Therapeutics has retained legal counsel from Cross-Border Counselor LLP, as mentioned by Wesley E. Johnson. The firm, accessible at www.cbcounselor.com, will assist with proactive measures to protect clients, including initiating legal action against counterfeiters and other illicit sellers. This move underscores the company's commitment to product integrity and consumer safety, aiming to curb the distribution of fake products that could harm users. The warning highlights the broader implications of counterfeit health products, which pose a critical public health issue by potentially containing harmful or ineffective ingredients, risking the well-being of unsuspecting consumers. By urging purchases through verified channels, Bryan Therapeutics aims to safeguard its community and maintain the reputation of its scientifically-backed products, reflecting a growing trend in the health industry to combat fraud and ensure product safety in an increasingly digital marketplace.